- #772678
- 2,341
- Glaxo Smith Kline #58160084252
Boostrix® Tdap Booster Vaccine Indicated for People 10 Years of Age and Older Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed Injection Prefilled Syringe 0.5 mL
BOOSTRIX, TDAP SYR 2.5-8.5MG/0.5ML 0.5ML (10/PK)
Features
- BOOSTRIX® is indicated for active booster immunization against tetanus, diphtheria, and pertussis
- Syringe (tip cap may contain latex; plunger contains no latex) in Package of 10
- More …
Product Details Email
Product Specifications
McKesson # | 772678 |
Manufacturer # | 58160084252 |
Brand | Boostrix® |
Manufacturer | Glaxo Smith Kline |
Country of Origin | Unknown |
Application | Tdap Booster Vaccine |
Container Type | Prefilled Syringe |
Dosage Form | Injection |
Generic Drug Code | 24619 |
Generic Drug Name | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
NDC Number | 58160084252 |
Product Dating | McKesson Acceptable Dating: we will ship >= 180 days |
Storage Requirements | Requires Refrigeration |
Strength | 5 Lf - 2.5 Lf - 8 mcg / 0.5 mL |
Type | Intramuscular |
UNSPSC Code | 51201631 |
User | Indicated for People 10 Years of Age and Older |
Volume | 0.5 mL |
Features
- BOOSTRIX® is indicated for active booster immunization against tetanus, diphtheria, and pertussis
- Syringe (tip cap may contain latex; plunger contains no latex) in Package of 10
More Information
Professionals Also Viewed
- #520319
- 284
- Glaxo Smith Kline #58160084211
- BOOSTRIX® is indicated for active booster immunization against tetanus …